Citation

BibTex format

@inproceedings{Pinato:2024:10.1200/JCO.2024.42.3_suppl.374,
author = {Pinato, DJ and Jones, RH and Forster, MD and Joshua, AM and Korolewicz, J and Benafif, S and Aboud, K and Liu, JJ and Cosman, R and Paull, J and Fairley, J and Edmondson, SR and Spicer, JF},
doi = {10.1200/JCO.2024.42.3_suppl.374},
pages = {374--374},
publisher = {LIPPINCOTT WILLIAMS & WILKINS},
title = {Efficacy and safety of dendrimer-enhanced (DEP) cabazitaxel (CTX-SPL9111) in advanced esophagogastric cancers in a phase 1/2 trial.},
url = {http://dx.doi.org/10.1200/JCO.2024.42.3_suppl.374},
year = {2024}
}
Download

RIS format (EndNote, RefMan)

TY  - CPAPER
AU  - Pinato,DJ
AU  - Jones,RH
AU  - Forster,MD
AU  - Joshua,AM
AU  - Korolewicz,J
AU  - Benafif,S
AU  - Aboud,K
AU  - Liu,JJ
AU  - Cosman,R
AU  - Paull,J
AU  - Fairley,J
AU  - Edmondson,SR
AU  - Spicer,JF
DO  - 10.1200/JCO.2024.42.3_suppl.374
EP  - 374
PB  - LIPPINCOTT WILLIAMS & WILKINS
PY  - 2024///
SN  - 0732-183X
SP  - 374
TI  - Efficacy and safety of dendrimer-enhanced (DEP) cabazitaxel (CTX-SPL9111) in advanced esophagogastric cancers in a phase 1/2 trial.
UR  - http://dx.doi.org/10.1200/JCO.2024.42.3_suppl.374
ER  -
Download